Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas-Reference-Cited by-同舟云学术

Genomic Correlates of Disease Progression and Treatment Response in Prospectively Characterized Gliomas

Published:2019-07-01 Issue:18 Volume:25 Page:5537-5547
ISSN:1078-0432
Container-title:Clinical Cancer Research
language:en
Short-container-title:Clin Cancer Res

Author:

Jonsson Philip^ORCID,Lin Andrew L.,Young Robert J.^ORCID,DiStefano Natalie M.,Hyman David M.,Li Bob T.^ORCID,Berger Michael F.,Zehir Ahmet^ORCID,Ladanyi Marc,Solit David B.,Arnold Angela G.^ORCID,Stadler Zsofia K.,Mandelker Diana,Goldberg Michael E.^ORCID,Chmielecki Juliann,Pourmaleki Maryam,Ogilvie Shahiba Q.,Chavan Shweta S.,McKeown Andrew T.,Manne Malbora,Hyde Allison,Beal Kathryn,Yang T. Jonathan,Nolan Craig P.,Pentsova Elena,Omuro Antonio,Gavrilovic Igor T.,Kaley Thomas J.,Diamond Eli L.^ORCID,Stone Jacqueline B.^ORCID,Grommes Christian^ORCID,Boire Adrienne^ORCID,Daras Mariza^ORCID,Piotrowski Anna F.,Miller Alexandra M.,Gutin Philip H.,Chan Timothy A.,Tabar Viviane S.,Brennan Cameron W.,Rosenblum Marc,DeAngelis Lisa M.,Mellinghoff Ingo K.,Taylor Barry S.

Funder

NIH

National Brain Tumor Society

American Cancer Society

Sontag Foundation

Josie Robertson Foundation

Publisher

American Association for Cancer Research (AACR)

Subject

Cancer Research,Oncology

Cited by 114 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. HOXD12 defines an age-related aggressive subtype of oligodendroglioma;Acta Neuropathologica;2024-09-11

2. A real-world observation of patients with glioblastoma treated with a personalized peptide vaccine;Nature Communications;2024-08-11

3. The landscape of cancer-associated transcript fusions in adult brain tumors: a longitudinal assessment in 140 patients with cerebral gliomas and brain metastases;Frontiers in Oncology;2024-07-17

4. Genetic and epigenetic instability as an underlying driver of progression and aggressive behavior in IDH-mutant astrocytoma;Acta Neuropathologica;2024-07-16

5. The biological significance of tumor grade, age, enhancement, and extent of resection in IDH-mutant gliomas: How should they inform treatment decisions in the era of IDH inhibitors?;Neuro-Oncology;2024-06-24